Controversy over Lonza’s rights to pollute

Spread the love

By announcing Monday evening the sale of its chemical specialties division (LSI), Lonza was predisposed to find itself again on the front of the stage. Bain Capital and Cinven, two investment funds, will buy the entity put up for sale in 2020 for 4.2 billion francs.

However, it is for another financial matter that the manufacturer of the active principle of Moderna’s vaccine hit the headlines on Tuesday: while for fifty years it has emitted nitrous oxide, a powerful greenhouse gas in Valais, it could, according to the Daily indicator, derive a profit of several million francs from the process of cleaning up its production.